US · ADGM
Adagio Medical Holdings, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Laguna Hills, DE 92653
- Website
- adagiomedical.com
Price · as of 2024-12-31
$1.03
Market cap 15.22M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $15.18 | +1,373.79% |
| Intrinsic Value(DCF) | $0.42 | -59.22% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $6.43 | +524.17% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | $0.00 | $25.37 | |||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $1.06 | $15.18 | $0.00 | $0.00 | $6.43 |
AI valuation
Our deep-learning model estimates Adagio Medical Holdings, Inc.'s (ADGM) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $15.18
- Current price
- $1.03
- AI upside
- +1,373.79%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$0.42
-59.22% upside
Graham-Dodd
—
— upside
Graham Formula
$6.43
+524.17% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| ADGM | Adagio Medical Holdings, … | $1.03 | 15.22M | +1,374% | -59% | — | +524% | -0.21 | 0.81 | 59.89 | -0.19 | — | -15.73 | -620.07% | -23226.77% | -19986.25% | 133.87% | 157.35% | -271.53% | 0.82 | 56.70 | 3.27 | 2.66 | 0.07 | -2716.00% | -1033.00% | 1971.00% | -193.09% | -3.79 | 78.34% | 0.00% | 0.00% | 256.59% | -0.19 | -0.38 | 43.83 | -5.52 |
| ALUR | Allurion Technologies Inc… | $1.17 | 9.09M | +15,409% | -17% | — | +29,866% | -0.21 | -0.07 | 0.17 | -1.26 | — | -0.07 | 66.97% | -156.33% | -81.43% | 35.22% | 82.22% | -50.03% | -0.49 | -22.17 | 1.44 | 1.19 | -1.02 | -7987.00% | -3994.00% | -3457.00% | -785.83% | -2.24 | 70.29% | 0.00% | 0.00% | 0.00% | -0.56 | -0.65 | 0.87 | -13.22 |
| ATHA | Athira Pharma, Inc. | $6.75 | 26.62M | — | — | — | — | -0.14 | 0.29 | — | 0.38 | — | 0.29 | 0.00% | — | — | -110.77% | 967.28% | -88.52% | 0.03 | — | 4.18 | 3.90 | 0.49 | -1845.00% | — | -381.00% | -740.33% | -7.40 | 931.82% | 0.00% | 0.00% | 0.00% | 0.37 | 0.38 | — | -13.92 |
| COCH | Envoy Medical, Inc. | $0.72 | 15.07M | +3,147% | -23% | — | +2,867% | -1.16 | -1.39 | 116.08 | -2.03 | — | -1.39 | -229.78% | -8558.22% | -9242.22% | 217.79% | 381.46% | -226.68% | -1.04 | -23.60 | 1.24 | 0.84 | -0.72 | -4134.00% | -2880.00% | 977.00% | -72.47% | -2.38 | 374.98% | 9.37% | -10.90% | 9.37% | -2.09 | -2.13 | 179.09 | -39.33 |
| CODX | Co-Diagnostics, Inc. | $2.30 | 2.57M | +1,244% | +270% | — | +1,660% | -13.54 | 9.38 | 130.17 | -12.45 | -406.20 | 18.07 | 74.48% | -1023.75% | -961.37% | -53.65% | -140.21% | -47.25% | 0.04 | — | 4.41 | 4.08 | 0.02 | 333.00% | -4253.00% | 2754.00% | -5.87% | -3.99 | -104.61% | 0.00% | 0.00% | 0.00% | -12.03 | -16.12 | 123.12 | 29.30 |
| CTXR | Citius Pharmaceuticals, I… | $0.74 | 8.27M | — | — | — | — | -0.33 | 0.19 | — | -0.28 | — | -0.38 | 0.00% | — | — | -57.75% | -58.28% | -32.10% | 0.03 | -143.87 | 0.62 | 0.09 | 0.06 | -4338.00% | — | -585.00% | -203.36% | -0.59 | -40.17% | 0.00% | 0.00% | 0.00% | -0.28 | -0.40 | — | -3.53 |
| IRIX | IRIDEX Corporation | $1.40 | 24.07M | +1,616% | -64% | — | — | -2.32 | 9.88 | 0.43 | -3.34 | — | -118.36 | 40.07% | -17.06% | -18.31% | -153.37% | -173.19% | -28.03% | 2.21 | — | 1.42 | 0.65 | -0.33 | -847.00% | -617.00% | 648.00% | -35.23% | -0.44 | -152.25% | 0.00% | 0.00% | 0.00% | -2.77 | -3.15 | 0.47 | -2.75 |
| LPTX | Leap Therapeutics, Inc. | $0.62 | 25.83M | — | — | — | — | -0.24 | 0.47 | — | 0.46 | — | 0.47 | 0.00% | — | — | -141.94% | 631.86% | -110.79% | 0.01 | — | 3.41 | 3.41 | 0.70 | -5452.00% | — | 3782.00% | -365.79% | -4.28 | 543.85% | 1.42% | -0.30% | 1.42% | 0.44 | 0.51 | — | -16.49 |
| NVNO | enVVeno Medical Corporati… | $10.00 | 165.03K | — | — | — | — | -0.07 | 0.04 | — | 1.91 | — | 0.04 | 0.00% | — | — | -49.39% | -3781.90% | -46.63% | 0.03 | — | 20.88 | 20.60 | 0.03 | -3351.00% | — | -1067.00% | -1122.35% | -8.04 | -2678.57% | 0.00% | 0.00% | 0.00% | 1.70 | 2.41 | — | -5.04 |
| VSEE | VSee Health, Inc. | $0.37 | 6M | +42,033% | +36% | — | — | -0.22 | -696.04 | 1.23 | -6.58 | -0.02 | -0.81 | 68.87% | -596.38% | -553.69% | 2890.35% | -2137.95% | -554.87% | -516.43 | -293.91 | 0.16 | 0.14 | -2.75 | 138684.00% | 8074.00% | 81765.00% | -45.42% | -0.30 | -206.78% | 0.00% | 0.00% | 0.00% | -0.36 | -3.78 | 2.12 | -15.05 |
| VVOS | Vivos Therapeutics, Inc. | $1.40 | 8.25M | +1,347% | +8,020% | — | — | -1.66 | 2.33 | 1.23 | -1.31 | — | 3.91 | 60.00% | -74.32% | -74.09% | -266.25% | -562.91% | -85.62% | 0.19 | — | 1.50 | 1.34 | 0.45 | -8007.00% | 891.00% | 400.00% | -71.58% | -2.55 | -668.13% | 0.00% | 0.00% | 27.53% | -1.23 | -1.04 | 0.92 | -9.26 |
About Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
- CEO
- Todd Usen
- Employees
- 80
- Beta
- 0.13
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($0.42 ÷ $1.03) − 1 = -59.22% (DCF, example).